Signing of Licence with Major Japanese Corporation
Xaar PLC
24 February 2000
Xaar plc - Major New Licence
Xaar plc, the Cambridge-based inkjet printing technology group,
has today announced the signing of a significant new licence with
a major Japanese Corporation.
Graham Wylie, Chief Executive of Xaar said, 'We are delighted to
announce this major new licence deal with a world leader in
consumer electronics and office printing, although disappointed
that we are, at the request of the licensee, currently unable to
disclose their identity at present.
'Following on from our excellent results for 1999 announced last
week, this represents a very encouraging start to the current
year'.
Xaar now has ten licensees for its ink jet printing technology
and is pursuing several other opportunities. Products containing
the Xaar technology are currently being shown at CeBIT - the IT
show in Hanover - and will be launched at DRUPA 2000 - the
digital printing show held every 5 years in Dusseldorf in May.
Graham Wylie, Chief Executive or Jonathan Lowe, Finance Director
at Xaar on Tel: 01223-423663
Steve Liebmann or Lisa Baderoon at Buchanan Communications on
Tel: 020 7-466-5000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.